In 22 (15 MDS, 4 AML, 3 CMML, patient characteristics see Table 1) of the 27 patients we investigated the PD-1 promoter methylation in sorted CD4+ and CD8+ T cells. This evidence concerns the gene CD4 and myelodysplastic syndrome.